Haemonetics Corporation (HAE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$62.91
Day's range
$64.78

Haemonetics Corp. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 5.82 M $466.55 M   -3.32% 12.44%
VANGUARD GROUP INC 01/29/2026 4.76 M $381.60 M   -1.52% 10.18%
NEUBERGER BERMAN GROUP LLC 02/13/2026 3.87 M $309.88 M   5.32% 8.26%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 3.16 M $253.52 M   48.58% 6.76%
STATE STREET CORP 02/13/2026 1.73 M $138.65 M   -3.94% 3.70%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 1.38 M $110.62 M   994.74% 2.95%
FMR LLC 02/17/2026 1.33 M $106.35 M   9.14% 2.84%
CITADEL ADVISORS LLC 02/17/2026 1.29 M $103.27 M   481.87% 2.75%
HOLOCENE ADVISORS, LP 02/17/2026 1.26 M $101.33 M   3,148.38% 2.70%
GOLDMAN SACHS GROUP INC 03/25/2026 1.23 M $98.31 M   110.49% 2.62%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.19 M $95.76 M   -0.73% 2.55%
NORTH PEAK CAPITAL MANAGEMENT, LLC 02/13/2026 1.10 M $88.40 M   204.39% 2.36%
RIVER ROAD ASSET MANAGEMENT, LLC 02/24/2026 1.10 M $88.34 M   -33.40% 2.36%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.09 M $87.60 M   -0.60% 2.34%
ROYAL BANK OF CANADA 02/17/2026 967.59 K $77.55 M   -23.26% 2.07%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/19/2026 943.19 K $75.60 M   -6.70% 2.02%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 939.73 K $75.16 M   -11.41% 2.01%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 853.38 K $68.40 M   1,882.25% 1.82%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 01/13/2026 717.00 K $57.47 M   1.51% 1.53%
BOSTON TRUST WALDEN CORP 01/28/2026 580.65 K $46.54 M   -39.31% 1.24%
NORTHERN TRUST CORP 02/17/2026 577.73 K $46.30 M   -4.09% 1.23%
SILVERCREST ASSET MANAGEMENT GROUP LLC 02/17/2026 573.65 K $45.98 M   -10.59% 1.23%
CITIGROUP INC 02/13/2026 569.17 K $45.62 M   32.66% 1.22%
MORGAN STANLEY 02/13/2026 562.95 K $45.12 M   8.09% 1.20%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 548.92 K $44.00 M   -2.29% 1.17%
UBS GROUP AG 01/29/2026 539.68 K $43.26 M   -62.85% 1.15%
JANE STREET GROUP, LLC 02/12/2026 526.29 K $42.18 M   85.48% 1.12%
BARROW HANLEY MEWHINNEY & STRAUSS LLC 02/11/2026 523.11 K $41.93 M   -6.58% 1.12%
BANK OF AMERICA CORP /DE/ 02/17/2026 482.17 K $38.65 M   44.23% 1.03%
FRANKLIN RESOURCES INC 02/11/2026 464.10 K $37.20 M   -26.01% 0.99%
MARSHALL WACE, LLP 02/13/2026 432.96 K $34.70 M   -6.65% 0.93%
DEUTSCHE BANK AG\ 02/11/2026 401.76 K $32.20 M   38.77% 0.86%
ARISTOTLE CAPITAL BOSTON, LLC 02/17/2026 370.31 K $29.68 M   -8.38% 0.79%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 359.19 K $28.79 M   -0.97% 0.77%
BOSTON PARTNERS 02/13/2026 322.67 K $25.77 M   -43.48% 0.69%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 02/09/2026 314.65 K $25.22 M   -33.99% 0.67%
BANK OF NEW YORK MELLON CORP 02/10/2026 305.22 K $24.46 M   -12.82% 0.65%
MIZUHO MARKETS AMERICAS LLC 02/06/2026 278.31 K $22.31 M   110.34% 0.59%
MIZUHO MARKETS AMERICAS LLC 02/06/2026 278.31 K $271.24 K   100.00% 0.59%
LONDON CO OF VIRGINIA 02/17/2026 263.57 K $21.13 M   -0.93% 0.56%
JPMORGAN CHASE & CO 02/11/2026 256.55 K $20.56 M   -8.04% 0.55%
NUVEEN, LLC 02/12/2026 234.58 K $18.80 M   75.98% 0.50%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 225.63 K $18.08 M   -28.85% 0.48%
CITIGROUP INC 02/13/2026 220.00 K $17.63 M   100.00% 0.47%
JANUS HENDERSON GROUP PLC 02/17/2026 186.72 K $14.97 M   731.49% 0.40%
INVESCO LTD. 02/19/2026 168.73 K $13.52 M   2.92% 0.36%
RAYMOND JAMES FINANCIAL INC 02/18/2026 168.32 K $13.49 M   -48.10% 0.36%
SEI INVESTMENTS CO 02/13/2026 167.36 K $13.41 M   -0.15% 0.36%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 163.78 K $13.13 M   10.45% 0.35%
LOOMIS SAYLES & CO L P 02/12/2026 154.25 K $12.36 M   -31.24% 0.33%

Haemonetics Corp. institutional Ownership - FAQ's

During the previous two years, 519 institutional investors and hedge funds held shares of Haemonetics Corp.. The most heavily invested institutionals were:

River Road Asset Management, LLC: 1.33 M

DIMENSIONAL FUND ADVISORS LP: 1.33 M

Allspring Global Investments Holdings, LLC: 890,224

FORT WASHINGTON INVESTMENT ADVISORS INC /OH/: 841,017

Boston Partners: 556,679

UBS Group AG: 526,617

108.75% of Haemonetics Corp. stock is owned by institutional investors.

Institutional investors have bought a total of 68.65 M shares in the last 24 months. This purchase volume represents approximately $4.41 B in transactions.